NOV 24, 2017 10:34 AM PST

Discovery of Compound Provides New Hope for Treating Autoimmune Disease

WRITTEN BY: Kara Marker

The majority of drugs available for people with autoimmune diseases are only designed to alleviate symptoms, as opposed to targeting the root cause of disease. Thanks to the discovery of a new “drug-like compound,” University of Colorado at Boulder scientists believe they can work toward the development of new drugs that target the cause instead of just the symptoms.

Toll-like receptor 2 (TLR2). Credit: European Bioinformatics Institute

The new discovery starts with a component of the innate, or non-specific, immune system called toll-like receptor 8 (TLR8). Upon sensation of a pathogen, TLR8 triggers a domino reaction that changes the receptor from a passive state to an active state. Activate TLR8 releases inflammatory signals that are good for fighting bacteria and viruses, but bad for healthy tissues if the response goes overboard.

Historically, TLR8 has been difficult to study and apply as a drug target because it is “hidden inside the endosome,” while most drug targets are on the cell’s surface. The new CU Boulder study, in an effort to find a molecule to bind TLR8, completed high-throughput screening of more than 14,000 small molecule compounds. Out of the thousands, researchers zeroed in on just four with the potential to have the proper chemical structure for the job.

Using these four small molecules as a model, researchers chemically synthesized their own compound to bind TLR8, preventing TLR8 activity instead of silencing an already-active TLR8. "Before, people were trying to close the open door to shut it down. We found the key to lock the door from the inside so it never opens," explained lead author Hang Hubert Yin.

Yin calls the new synthesized compound and the approach to blocking TLR8 activation “paradigm shifting.”

In the future, Yin and his team plan on continuing their studies of the new TLR8-binding compound and its potential to treat a variety of autoimmune diseases that cause pain, inflammation, and other chronic health issues. Existing drugs can be costly and cause side effects, so the new compound could be the answer for many scientists looking for alternatives.

Yin is planning animal studies and human clinical trials, to learn more about TLR8 and other toll-like receptors.

The present study was published in the journal Nature Chemical Biology.

Source: University of Colorado at Boulder

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 30, 2020
Genetics & Genomics
How Are DNA Testing Companies Helping the Fight Against COVID?
JUL 30, 2020
How Are DNA Testing Companies Helping the Fight Against COVID?
One of the most puzzling characteristics of coronavirus is how some people develop severe symptoms and die from the dise ...
AUG 05, 2020
Immunology
Intercepting Cancer Cells Before They Can Dodge the Immune System
AUG 05, 2020
Intercepting Cancer Cells Before They Can Dodge the Immune System
The battle that naturally occurs between the body’s immune system and cancerous cells is one that scientists have ...
AUG 18, 2020
Immunology
How Dolphins Could Help Us Live Longer
AUG 18, 2020
How Dolphins Could Help Us Live Longer
Dolphins are helping scientists answer the age-old question: can we stop the clock when it comes to aging? A recent stud ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
NOV 24, 2020
Immunology
Dirty Sheets Make Babies Healthier
NOV 24, 2020
Dirty Sheets Make Babies Healthier
Microbiologists have established that the development of infants’ immune systems is intricately linked to the dive ...
Loading Comments...